Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Nov 15, 2023; 15(11): 1874-1890
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1874
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1874
Characteristics | Cancer-specific survival (months after diagnosis) | ||||||||
0 | d | 2 | d | 4 | d | 6 | d | ||
Overall | 34.77 | 42.48 | 48.6 | 55.11 | |||||
Age, yr | |||||||||
< 55 | 32.05 | 43.36 | 53.19 | 66.41 | |||||
55-65 | 36 | 0.08 | 41.63 | -0.04 | 45.44 | -0.16 | 42.52 | -0.48 | |
≥ 65 | 34.79 | 0.06 | 43.05 | -0.01 | 50.09 | -0.06 | 56.97 | -0.19 | |
Gender | |||||||||
Female | 36.67 | 45.76 | 54.64 | 58.38 | |||||
Male | 34.35 | -0.05 | 41.77 | -0.08 | 47.24 | -0.15 | 54.33 | -0.08 | |
Race | |||||||||
Black | 36.22 | 43.24 | 49.22 | 55.84 | |||||
White | 36.31 | 0.00 | 44.26 | 0.02 | 49.36 | 0.00 | 56.34 | 0.01 | |
Other | 28.31 | -0.17 | 35.2 | -0.16 | 44.84 | -0.09 | 50.3 | -0.11 | |
Marital status | |||||||||
Married | 34.01 | 41.82 | 47.37 | 55.74 | |||||
Single | 35.15 | 0.02 | 43.06 | 0.03 | 52.07 | 0.09 | 54.74 | -0.02 | |
Separated | 36 | 0.04 | 43.25 | 0.03 | 47.46 | 0.00 | 54.23 | -0.03 | |
AFP expression | |||||||||
Positive | 32.75 | 44.94 | 45.3 | 51.21 | |||||
Negative | 45.67 | 0.27 | 51.74 | 0.14 | 62.82 | 0.35 | 70 | 0.38 | |
Tumor size | |||||||||
≤ 5 cm | 40.79 | 51.88 | 64.07 | 62.94 | |||||
> 5 cm | 32.51 | -0.17 | 38.86 | -0.26 | 42.46 | -0.43 | 51.42 | -0.23 | |
T stage | |||||||||
T1 | 41.66 | 50.32 | 57.88 | 62.8 | |||||
T2 | 40.4 | -0.03 | 51.47 | 0.02 | 59.43 | 0.03 | 57.77 | -0.10 | |
T3 | 30.68 | -0.23 | 36.49 | -0.28 | 42.85 | -0.30 | 51.69 | -0.22 | |
T4 | 32.82 | -0.19 | 40.66 | -0.20 | 38.16 | -0.39 | 46.15 | -0.33 | |
N stage | |||||||||
N0 | 36.48 | 44.7 | 51.36 | 62.39 | |||||
N1 | 31.00 | -0.12 | 37.11 | -0.15 | 41.57 | -0.20 | 44.53 | -0.36 | |
Surgery | |||||||||
No | 32.69 | 39.81 | 45.84 | 52.64 | |||||
Yes | 69.51 | 0.77 | 73.97 | 0.69 | 74.6 | 0.58 | 73.6 | 0.42 | |
Chemotherapy | |||||||||
No/unknown | 24.05 | 37.52 | 48.05 | 56.21 | |||||
Yes | 43.68 | 0.41 | 45.05 | 0.15 | 48.87 | 0.02 | 54.64 | -0.03 | |
Radiotherapy | |||||||||
No/unknown | 30.92 | 39.7 | 47.66 | 55.55 | |||||
Yes | 49.75 | 0.40 | 50.72 | 0.22 | 51 | 0.07 | 54.05 | -0.03 | |
Lung metastasis | |||||||||
No | 40.69 | 46.02 | 49.33 | 53.7 | |||||
Yes | 24.4 | -0.34 | 34.24 | -0.24 | 46.61 | -0.05 | 59.18 | 0.11 | |
Bone metastasis | |||||||||
No | 33.52 | 41.03 | 48.1 | 55.99 | |||||
Yes | 37.84 | 0.09 | 45.87 | 0.10 | 49.79 | 0.03 | 53.21 | -0.06 | |
Brain metastasis | |||||||||
No | 34.83 | 42.5 | 48.59 | 54.78 | |||||
Yes | 31.91 | -0.06 | 42.48 | -0.0004 | 48.61 | 0.0004 | 64.46 | 0.19 |
- Citation: Yang YP, Guo CJ, Gu ZX, Hua JJ, Zhang JX, Shi J. Conditional survival probability of distant-metastatic hepatocellular carcinoma: A population-based study. World J Gastrointest Oncol 2023; 15(11): 1874-1890
- URL: https://www.wjgnet.com/1948-5204/full/v15/i11/1874.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i11.1874